Register for updates

 
 

Medicine & Health
RSS Feed
Prof. Illana Gozes Receives Top RARE Gene Award
Wednesday, September 28, 2016 9:00:00 AM

World-renowned neuroscientist and geneticist celebrated for "commitment to research and new therapies"

Prof. Illana GozesTel Aviv University's Prof. Illana Gozes was awarded the 2016 RARE Champion of Hope — Science International Prize by Global Genes, a leading global advocacy non-profit organization for patients and families fighting rare and genetic diseases.

The ceremony took place at the 5th Annual Tribute to Champions of Hope presented by PRA Health Sciences on September 23 and 24 at the Huntington Beach Hyatt Resort and Spa in Aliso Viejo, CA. The annual blue carpet event honors and celebrates rare disease advocates, scientists, patients, and supporters.

Prof. Gozes is the incumbent of the Lily and Avraham Gildor Chair for the Investigation of Growth Factors; Head of the Elton Laboratory for Molecular Neuroendocrinology at TAU's Sackler Faculty of Medicine; and a member of TAU's Adams Super Center for Brain Studies and Sagol School of Neuroscience.

More than 350 individuals and organizations worldwide were nominated by members of the Global Genes Board of Directors and Medical and Science Advisory Board for their notable efforts in rare disease advocacy, science, collaborative sciences, and medical care and treatment. Only a few of the nominees were selected for the top honor.

A leader in genetic research

Prof. Gozes is a vanguard on the front of genetic research. She discovered the ADNP gene that causes the ADNP syndrome (also known as the Helsmoortal-Van Der AA syndrome), deregulates in Alzheimer's disease (AD) and in schizophrenia, and mutates in autism. Prof. Gozes has also been instrumental in drawing attention to the ways that ADNP binds to microtubules — tubes within nerve cells that maintain cell shape and serve as "train tracks" for movement of biological material through the brain.

"With her commitment to research and new therapies, Prof. Gozes continues to help many undiagnosed patients receive the therapies and tests needed to be happy, healthy, and diagnosed," according to Global Genes.

"There is no one else more worthy of receiving this award than Prof. Gozes," said Angela Downing, Chair of the ADNP Kids Research Foundation, who presented the award to Prof. Gozes. "She is a respected neuroscientist, a beloved professor and a mentor to many. She has worked tirelessly in her career not only for science but for humanity. Prof. Gozes delivers nothing but excellence in terms of research. Her commitment to our children, who suffer from ADNP disorders, is strong and we stand confident knowing she stands with us."

Sandra Sermone, Founder and President of the ADNP Kids Research Foundation, added: "I have known Prof. Gozes for the last two years, after my son was diagnosed with an ADNP mutation. She is a leader in ADNP research and drug development and works tirelessly to advance research and potential treatments for our children with this heart-breaking disease. She is committed, caring and compassionate. There is no one more deserving of an award associated with hope."

Praising a community

Global Genes is a leading global advocacy non-profit organization for patients and families fighting rare and genetic diseases. The organization hopes to find treatments and cures for the 7,000+ rare and genetic diseases that affect an estimated 30 million Americans and over 350 million people worldwide through building awareness, developing patient-focused educational tools, and funding patient care programs and early investigative research.

"I feel privileged to have helped this community," said Prof. Gozes. "I may have been able to help only a few families, but then they discussed the experience and passed on vital information to others in similar situations. Together, as a community, they have a voice which calls for more funding to support further critical research."

Together with Coronis Neurosciences (on agreement with Ramot@Tel Aviv University), Prof. Gozes is currently developing an ADNP-based drug for cognitive impairment in schizophrenia. A small fragment of ADNP called davunetide has shown promise in Phase IIa clinical trials, and Prof. Gozes is harnessing it for further advanced trials on large cohorts of patients. The exposure to the knowledgeable and compassionate community of Global Genes and the honor of receiving the RARE Champion of Hope — Science International Prize will no doubt accelerate drug development.

Click on the arrow buttons to move forward and back, and the pause button to stop.




Latest News

Genetically Encoded Sensor Isolates Hidden Leukemic Stem Cells

Cells express surface markers that help them escape most targeted therapies, TAU researchers say.

Be Nice to Your Doctor — You May Receive Better Care

Under most conditions, positive social interactions have beneficial implications for employee performance, say TAU researchers.

PCV Vaccine Leads to Steep Decline in Childhood Hospitalizations Due to Community-Acquired Bacteremia

Vaccine also decreased antibiotic resistance patterns, TAU researchers say.

Physicists Solve 35-Year-Old Mystery About Quarks

Number of proton-neutron pairs in an atom determines how fast particles move, say TAU, MIT, Thomas Jefferson researchers.

New Blood Test May Map Fetal Genome for Countless Mutations

Test could detect innumerable diseases caused by minuscule impairments in the fetal genome, TAU researchers say.

New Imaging Technology Captures Movement of Quantum Particles With Unprecedented Resolution

Method paves the way for ultrafast control and extreme spatiotemporal imaging of condensed matter, TAU researchers say.

Lightning's Electromagnetic Fields May Have Protective Properties

Extremely low frequency fields may have played an evolutionary role in living organisms, say TAU researchers.

Study Links Adult Fibromyalgia to Childhood Sexual Abuse

Hyperbaric oxygen therapy sessions are an effective treatment, TAU researchers say.

Adolescents With Celiac Disease Are at Higher Risk of Eating Disorders

Overweight teenage girls with CD are at highest risk of developing early hallmarks of full-blown eating disorders, TAU researchers say.

White Blood Cells Related to Allergies and Asthma May Also Be Harnessed to Destroy Cancer Cells

Eosinophil immune cells are capable of killing colon cancer cells, TAU researchers say.

contentSecondary
c

© 2019 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University